HGH, CJC-1295, and MK-677: separating hype from human data

What did @newtonbuilt actually say?

The creator ran through a personal comparison of two growth hormone secretagogues, MK-677 and CJC-1295, and announced plans to start exogenous HGH at 2 IU daily, titrating toward 4 to 6 IU. His framing was honest about his own bad experience with MK-677, saying it "fucked my sleep" and caused prolactin-related nipple sensitivity. He described CJC-1295 as "extremely mild and smooth" but dismissed it for bodybuilding as "negligible." The video ends with a commitment to follow his HGH journey publicly.

Credit where it's due: he's not selling anything in this clip, and he acknowledged personal side effects rather than glossing over them. That's rarer than it should be in this corner of fitness content.

Does the science back this up?

Partly. His description of MK-677 side effects is consistent with published data. The IGF-1 muscle-building claim is real but oversimplified, and his dismissal of CJC-1295 as negligible is worth scrutinizing.

MK-677 (ibutamoren) works as a ghrelin receptor agonist, which is exactly why his sleep and cortisol complaints track. Ghrelin signaling affects circadian rhythm and HPA axis activity. A 2008 study by Nass et al. in the Journal of Clinical Endocrinology and Metabolism found MK-677 increased IGF-1 but also raised fasting glucose and cortisol in older adults. The prolactin elevation he experienced is less commonly reported but documented in user populations. As for CJC-1295, a 2006 trial by Ionescu and Frohman in JCEM showed sustained GH pulse amplification, which is not nothing, but whether that translates to meaningful body composition changes in healthy trained individuals is genuinely unclear.

What did they get wrong (or right)?

He got the MK-677 side effect profile broadly right. Where he stumbles is the IGF-1 to muscle pipeline claim. IGF-1 elevation does not straightforwardly equal "build more muscle." The relationship is far more conditional.

A 2010 meta-analysis by Liu et al. in the Annals of Internal Medicine examined GH supplementation in healthy adults and found modest lean mass increases alongside significant side effect burden, with no consistent strength gains. Elevated IGF-1 also carries longer-term concerns. The IGF-1 and cancer risk relationship is observational and not causal, but researchers like Renehan et al. (2004, Lancet) flagged associations with colorectal and prostate cancer in high-IGF-1 populations. Ignoring that in a public video aimed at bodybuilders is an omission worth naming.

His planned HGH range of 4 to 6 IU is on the aggressive end. This article will not recommend any dose, but readers should know that doses above 1 to 2 IU daily in non-deficient adults are associated with carpal tunnel syndrome, edema, and insulin resistance per the Liu et al. meta-analysis.

What should you actually know?

These are not interchangeable tools, and none of them are risk-free, including CJC-1295. The "mild and smooth" description is not the same as safe, especially over extended use.

MK-677 has a genuinely messy side effect profile in real-world use. Sleep disruption from ghrelin agonism is well-supported. Cortisol elevation is documented. The prolactin sensitivity he described is less frequently studied but consistent with anecdotal clinical reports. CJC-1295 acts on a different axis entirely, stimulating pituitary GH release through GHRH receptor binding, so comparing them as equivalent "GH secretagogues" with the same mechanism is imprecise. Exogenous HGH, which he is planning to use, is a different category altogether: a pharmaceutical requiring a prescription, not a secretagogue. Compounded HGH is not equivalent to approved brand-name somatropin products, and anyone considering it should be under physician supervision with baseline IGF-1 testing and ongoing monitoring. If your nipples are getting sensitive on any GH-related compound, that is a reason to stop and get labs, not a minor footnote.

Bottom line: what's the verdict?

The creator is describing real pharmacology with real personal experience, which puts this video above average for the category. But the IGF-1 to muscle claim is oversimplified, the risk picture is incomplete, and announcing a 4 to 6 IU HGH titration target to 65,000 viewers without context about monitoring, contraindications, or prescription requirements is irresponsible regardless of intent.

Growth hormone is not a bodybuilding cheat code. It is a tightly regulated hormone with a well-documented adverse effect profile when used outside of clinical deficiency contexts. Framing this as a "journey" rather than a medical decision obscures what it actually is.